Reported Reactions

Devices › Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator

Device brand name · Mesh surgical synthetic urogynecologic

Gynecare Tvt Abrevo Continence System: medical device reports filed with FDA

324 reports name it, 2013–2017. Manufacturer given most often on reports: Ethicon. Product code OTN.

324
device reports naming the brand
0% of all MAUDE reports · about 25 a year
0
reports, 12 months to August 2026
0 in the 12 months before
4.3%
classified as malfunction
1.6% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 324 reports that name the brand "Gynecare Tvt Abrevo Continence System" (mesh surgical synthetic urogynecologic), received between June 2013 and November 2017; the manufacturer given most often on reports is Ethicon. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (95.7%) and malfunction (4.3%); across all mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator reports (product code OTN) death is recorded in 1% and malfunction in 1.6%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are material erosion (74.4%), migration or expulsion of device (7.7%) and other (for use when an appropriate device code cannot be identified) (7.1%). The patient problems coded most often are erosion, pain and surgical procedure. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Gynecare Tvt Abrevo Continence System was received in the five years to August 2026; the latest was received in November 2017.

By year received

01102202013: 22020132014: 3520142015: 4720152016: 1220162017: 102017

Event type and report source

Event type, as classified on the report

Death0%0
Injury95.7%310
Malfunction4.3%14
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%324
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 38,649 reports carrying product code OTN. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Material erosion24174.4%44.4%
Migration or expulsion of device257.7%5.2%
Other (for use when an appropriate device code cannot be identified)237.1%2.2%
Breakthe device broke103.1%0.3%
Bent10.3%0%
Insufficient device problem information10.3%8.4%
Material perforation10.3%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Erosion26782.4%
Painpain, site not specified26080.2%
Surgical procedure24575.6%
Other (for use when an appropriate patient code cannot be identified)12037%
Bleeding4513.9%
Scar tissue4012.3%
Incontinence288.6%
Neurological deficit/dysfunction278.3%
Micturition urgency154.6%
Urinary tract infectionbladder or urinary infection134%
Blood loss123.7%
Internal organ perforation123.7%
Urinary frequency / polyuria123.7%
Extrusion92.8%
Urinary retentionbeing unable to empty the bladder82.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGynecare Tvt Abrevo Continence SystemProduct code OTNAll MAUDE reports
Reports32438,64926,136,888
Share of that pool—0.8%0%
Classified as death, per 1,000 reports0109
Classified as injury95.7%97.4%36.2%
Classified as malfunction4.3%1.6%62.3%
Filed by the manufacturer100%97.8%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code OTN

BrandReportsLatest 12 monthsClassified as death
Gynecare Tvt Retropubic System5,75200%
Gynecare Tvt Obturator System4,33000%
Tension Free Vaginal Tape9,35500.1%
Gynecare Mesh Unknown5,83030.1%
Gynecare Tvt Oburator System1,57800.1%
Tension Free Vaginal Tape Unknown Product1,161240%
Gynecare Tvt-Aa Abdominal90500%
Advantage Fit System1,496100.1%
Gynecare Tvt Obturator868150%
Uretex Support Pp Kit X199900.1%
Gynecare Tvt Exact Continence System68200%
Tension Free Vaginal Tape - Obturator Unknown Prod67650%
Advantage? System3,537130%
Obtryx System6,03110%
Gynecare TVT67930%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Gynecare Tvt Abrevo Continence System reports

How many FDA reports name Gynecare Tvt Abrevo Continence System?

324 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (95.7%) and malfunction (4.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

material erosion (74.4%), migration or expulsion of device (7.7%), other (for use when an appropriate device code cannot be identified) (7.1%), break (3.1%) and bent (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Gynecare Tvt Abrevo Continence System was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.